Direkt zum Inhalt
Merck
  • Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats.

Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats.

Food & function (2015-07-21)
Sunil K Panchal, Hemant Poudyal, Leigh C Ward, Jennifer Waanders, Lindsay Brown
ZUSAMMENFASSUNG

Obesity and dyslipidaemia are metabolic defects resulting from impaired lipid metabolism. These impairments are associated with the development of cardiovascular disease and non-alcoholic fatty liver disease. Correcting the defects in lipid metabolism may attenuate obesity and dyslipidaemia, and reduce cardiovascular risk and liver damage. L-Carnitine supplementation was used in this study to enhance fatty acid oxidation so as to ameliorate diet-induced disturbances in lipid metabolism. Male Wistar rats (8-9 weeks old) were fed with either corn starch or high-carbohydrate, high-fat diets for 16 weeks. Separate groups were supplemented with L-carnitine (1.2% in food) on either diet for the last 8 weeks of the protocol. High-carbohydrate, high-fat diet-fed rats showed central obesity, dyslipidaemia, hypertension, impaired glucose tolerance, hyperinsulinaemia, cardiovascular remodelling and non-alcoholic fatty liver disease. L-Carnitine supplementation attenuated these high-carbohydrate, high-fat diet-induced changes, together with modifications in lipid metabolism including the inhibition of stearoyl-CoA desaturase-1 activity, reduced storage of short-chain monounsaturated fatty acids in the tissues with decreased linoleic acid content and trans fatty acids stored in retroperitoneal fat. Thus, L-carnitine supplementation attenuated the signs of metabolic syndrome through inhibition of stearoyl-CoA desaturase-1 activity, preferential β-oxidation of some fatty acids and increased storage of saturated fatty acids and relatively inert oleic acid in the tissues.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Carnitin Inneres Salz, synthetic, ≥98%
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
SKULieferanten-SKUPackungsgrößeVerfügbarkeitPreisMenge
EN300-179218-100MG100 mg
Versand in 14 Tagen - ab Aldrich Partner.
380,40 €
EN300-179218-250MG250 mg
Versand in 14 Tagen - ab Aldrich Partner.
527,30 €
EN300-179218-500MG500 mg
Versand in 14 Tagen - ab Aldrich Partner.
802,90 €
EN300-179218-1G1 g
Versand in 14 Tagen - ab Aldrich Partner.
1.017,40 €